Category: “Medical Device Manufactures”

Four vendors of MRI systems dominate the healthcare market: GE, Philips, Siemens, and Toshiba.

An interesting article from "The Economist" discusses the challenges and woes of Medical Device Manufactures all the way back in 2011. Was anyone paying attention? " SCANDALS, recalls, stingy customers, anxious regulators—any one of these would traumatize a chief executive. America's industry for medical devices is suffering from all of them. Omar Ishrak, the new boss of Medtronic, the world's biggest medical-technology company, recently described the problem succinctly to analysts: “There is a lot of work ahead of us.”

Interesting DR technology. Syncs with generator without a physical connection. Rotates the image without changing the panel's orientation.

Downward pressure on the orthopedic medical device sector from reimbursement and pricing, utilization of costly procedures, increasing commoditization, and the need to drive growth, are driving mergers and acquisitions at a fast pace.

Shimadzu Medical Systems USA, has been bestowed the 2014 "Best in KLAS" achievement award for the RADspeed table system in the "digital X-ray" category five out of six years.

Health technology and electronic health records powerhouse Cerner Corp. is spending $1.3 billion to purchase Siemens Health Services, the health information technology business of Germany’s Siemens AG, Cerner announced Tuesday.

Siemens is known for excellent engineering not necessarily customer messaging to the market that resonates powerfully. That seems to have changed with their new MAX messaging - Multiple Advances in X-ray. MedSalesReport certainly isn't plugging Siemens or their equipment. However their messaging is spot on. How does an OEM position big iron (or any iron for that matter) to the needs of value, clinical efficacy and economics in today's ACA world? Siemens has pulled that off masterfully here - something we would all do well to learn from.

Though developed countries such as the United States, Japan, and some nations in Europe still account for more than 60% of global medical device revenues, according to data from Decision Resources Group (DRG) and Millennium Research Group, these established medtech markets are providing diminishing returns for the industry thanks to factors including healthcare reform, cost containment measures, and regulatory pressures.